Is Enzolytics Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Enzolytics Inc (ENZC) is currently classified as DOUBTFUL as of March 2024. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Enzolytics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Enzolytics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Enzolytics Inc?

Muslim investors may consider investing in Enzolytics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Enzolytics Inc classified as DOUBTFUL?

Musaffa determines the Shariah status of Enzolytics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Enzolytics Inc updated?

The Shariah compliance status of Enzolytics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Enzolytics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Enzolytics Inc?

You can check the latest Shariah compliance status of Enzolytics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ENZC Shariah Compliance

Screening Methodology: AAOIFI

DOUBTFUL

Last Updated: March 26, 2024

Report Source: 2023 3rd Quarter Report

Enzolytics Inc. Stock Analysis ENZC

United States Health Care Nano Cap Report: Q3, 2023

Enzolytics, Inc. is a biotechnology company, which engages in the development and commercialization of drugs for infectious disease treatments. The company is headquartered in Plano, Texas. The company went IPO on 2008-12-29. The firm is focused on commercializing its licensed proprietary proteins and monoclonal antibodies to treat debilitating infectious diseases to include the additional contracted areas of sales, marketing and distribution of medical devices, medical testing and nutraceutical products. Its subsidiaries include BioClonetics lmmunotherapy, Inc. and Biogenysis, Inc.

Key Statistics of Enzolytics Inc (ENZC)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

2.21M

P/E Ratio (TTM)

52 Week Range

$0.00$0.00

Market Cap

1.69M

Avg. Volume

12.91M

Dividend Yield

Financial Metrics & Statements of Enzolytics Inc (ENZC)

FAQ's for Enzolytics Inc (ENZC)

According to Musaffa’s Shariah screening methodology, Enzolytics Inc (ENZC) is currently classified as DOUBTFUL as of March 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.